Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.
Publication
, Journal Article
Mahadeo, KM; Dhall, G; Ettinger, LJ; Kurer, CC
Published in: J Pediatr Hematol Oncol
March 2010
Cardiac disease is a significant complication of childhood oncologic therapy. We report the case of a 14-year-old female with acute promyelocytic leukemia who developed symptomatic cardiomyopathy only 4 months into treatment with a combination of daunomycin and all-trans retinoic acid (ATRA). Despite cessation of daunomycin, she demonstrated fluctuating systolic function in relation to ATRA administration. Improvement and deterioration in systolic function on echocardiogram and serum B-natriuretic peptide levels were seen while receiving ATRA 1 week on and 1 week off, respectively, during the maintenance phase of therapy.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Pediatr Hematol Oncol
DOI
EISSN
1536-3678
Publication Date
March 2010
Volume
32
Issue
2
Start / End Page
134 / 136
Location
United States
Related Subject Headings
- Tretinoin
- Oncology & Carcinogenesis
- Natriuretic Peptide, Brain
- Leukemia, Promyelocytic, Acute
- Humans
- Female
- Daunorubicin
- Chronic Disease
- Cardiomyopathies
- Antibiotics, Antineoplastic
Citation
APA
Chicago
ICMJE
MLA
NLM
Mahadeo, K. M., Dhall, G., Ettinger, L. J., & Kurer, C. C. (2010). Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction. J Pediatr Hematol Oncol, 32(2), 134–136. https://doi.org/10.1097/MPH.0b013e3181c95a0c
Mahadeo, Kris Michael, Girish Dhall, Lawrence J. Ettinger, and Cheryl C. Kurer. “Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.” J Pediatr Hematol Oncol 32, no. 2 (March 2010): 134–36. https://doi.org/10.1097/MPH.0b013e3181c95a0c.
Mahadeo KM, Dhall G, Ettinger LJ, Kurer CC. Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction. J Pediatr Hematol Oncol. 2010 Mar;32(2):134–6.
Mahadeo, Kris Michael, et al. “Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.” J Pediatr Hematol Oncol, vol. 32, no. 2, Mar. 2010, pp. 134–36. Pubmed, doi:10.1097/MPH.0b013e3181c95a0c.
Mahadeo KM, Dhall G, Ettinger LJ, Kurer CC. Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction. J Pediatr Hematol Oncol. 2010 Mar;32(2):134–136.
Published In
J Pediatr Hematol Oncol
DOI
EISSN
1536-3678
Publication Date
March 2010
Volume
32
Issue
2
Start / End Page
134 / 136
Location
United States
Related Subject Headings
- Tretinoin
- Oncology & Carcinogenesis
- Natriuretic Peptide, Brain
- Leukemia, Promyelocytic, Acute
- Humans
- Female
- Daunorubicin
- Chronic Disease
- Cardiomyopathies
- Antibiotics, Antineoplastic